- Hem
- Om universitetet
- Hitta person
- Anders Rosengren
Anders Rosengren
Professor
Sektionen för fysiologiOm Anders Rosengren
Forskargrupp
Anders Rosengren Group - Wallenbergcentrum för molekylär och translationell medicin
Projekt
-
Randomized open-label trial of semaglutide and dapagliflozin in patients with type 2 diabetes of different
pathophysiology
Chinmay Dwibedi, Ola Ekström, Jasmine Brandt, Martin Adiels, Stefan Franzén, Birgitta Abrahamsson, Anders H. Rosengren
Nature Metabolism - 2024 -
Digital lifestyle treatment improves long-term metabolic control in type 2 diabetes with different effects in pathophysiological and genetic
subgroups
Vishal A. Salunkhe, Neha Sinha, E. Ahlqvist, R. B. Prasad, S. Johansson, Birgitta Abrahamsson, Anders H. Rosengren
Npj Digital Medicine - 2023 -
Effect of self-managed lifestyle treatment on glycemic control in patients with type 2
diabetes
Chinmay Dwibedi, E. Mellergard, A. C. Gyllensten, K. Nilsson, Annika Axelsson, M. Backman, M. Sahlgren, S. H. Friend, S. Persson, Stefan Franzén, Birgitta Abrahamsson, K. S. Carlsson, Anders H. Rosengren
Npj Digital Medicine - 2022 -
Effect of Digital Lifestyle Management on Metabolic Control and Quality of Life in Patients with Well-Controlled Type 2
Diabetes
Chinmay Dwibedi, Birgitta Abrahamsson, Anders H. Rosengren
Diabetes Therapy - 2022 -
The role of circulating galectin-1 in type 2 diabetes and chronic kidney disease: evidence from cross-sectional, longitudinal and Mendelian randomisation
analyses
I. Drake, Emanuel Fryk, Lena Strindberg, Annika Lundqvist, Anders H. Rosengren, L. Groop, E. Ahlqvist, Jan Borén, M. Orho-Melander, Per-Anders Jansson
Diabetologia - 2022 -
Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six
variables
E. Ahlqvist, P. Storm, A. Karajamaki, M. Martinell, M. Dorkhan, A. Carlsson, P. Vikman, R. B. Prasad, D. M. Aly, P. Almgren, Y. Wessman, N. Shaat, P. Spegel, H. Mulder, E. Lindholm, O. Melander, O. Hansson, U. Malmqvist, A. Lernmark, K. Lahti, T. Forsen, T. Tuomi, Anders H. Rosengren, L. Groop
Lancet Diabetes & Endocrinology - 2018 -
Sulforaphane improves disrupted ER-mitochondria interactions and suppresses exaggerated hepatic glucose
production
E. Tubbs, A. S. Axelsson, G. Vial, C. B. Wollheim, J. Rieusset, Anders H. Rosengren
Molecular and Cellular Endocrinology - 2018 -
Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2
diabetes
A. S. Axelsson, E. Tubbs, B. Mecham, S. Chacko, H. A. Nenonen, Y. Z. Tang, J. W. Fahey, J. M. J. Derry, C. B. Wollheim, N. Wierup, M. W. Haymond, S. H. Friend, H. Mulder, Anders H. Rosengren
Science Translational Medicine - 2017 -
Aortic diameter at age 65 in men with newly diagnosed type 2
diabetes
S. Taimour, M. Zarrouk, J. Holst, Anders H. Rosengren, L. Groop, P. M. Nilsson, A. Gottsater
Scandinavian Cardiovascular Journal - 2017 -
Sox5 regulates beta-cell phenotype and is reduced in type 2
diabetes
A. S. Axelsson, T. Mahdi, H. A. Nenonen, T. Singh, S. Hänzelmann, A. Wendt, A. Bagge, T. M. Reinbothe, J. Millstein, X. Yang, B. Zhang, E. G. Gusmao, L. Shu, M. Szabat, Y. Tang, J. Wang, S. Salö, L. Eliasson, I. Artner, M. Fex, J. D. Johnson, C. B. Wollheim, J. M. J. Derry, B. Mecham, P. Spégel, H. Mulder, I. G. Costa, E. Zhang, Anders H. Rosengren
Nature Communications - 2017 -
Suppression of sulfonylurea- and glucose-induced insulin secretion in vitro and in vivo in mice lacking the chloride transport protein
ClC-3.
Dai-Qing Li, Xingjun Jing, Albert Salehi, Stephan C Collins, Michael B Hoppa, Anders H. Rosengren, Enming Zhang, Ingmar Lundquist, Charlotta S Olofsson, Matthias Mörgelin, Lena Eliasson, Patrik Rorsman, Erik Renström
Cell metabolism - 2009